Teva Pharmaceutical Industries (NASDAQ:TEVA) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research report issued to clients and investors on Friday, Analyst Ratings Network.com reports. The firm currently has a $49.00 price objective on the stock, up from their previous price objective of $38.00. JPMorgan Chase & Co.’s price objective points to a potential upside of 2.17% from the stocks previous close. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $48.94 in last session, and closed at $47.96, while the day range of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is $47.79 – $49.14. The stock showed a positive weekly performance of -3.73%.
GT Advanced Technologies Inc., (NASDAQ:GTAT), announced an innovative cell metallization and interconnect technology that is expected to provide substantial savings in both the the manufacture and installation of solar modules. GT Advanced Technologies Inc. (NASDAQ:GTAT) stock opened at $17.10 in last session, and closed at $16.23 by losing -4.53%. The 52 week range of $2.63 – $18.02. Company’s market capitalization is $1.98 billion.
Helen of Troy Limited (NASDAQ:HELE) announced the preliminary results of its modified “Dutch auction” tender offer to repurchase up to $300 million in value of its common shares. Helen of Troy Limited (NASDAQ:HELE) stock decreased -0.84% and finished the last session at $66.18. The EPS of the stock remained 3.31. Company’s market capitalization is $2.12 billion.
Allscripts Healthcare Solutions logo Allscripts Healthcare Solutions (NASDAQ:MDRX) has received an average rating of “Hold” from the twenty-three analysts that are covering the company, AR Network reports. Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) stock opened the session at $18.75, and closed the session at $18.76. The 52 week range of the Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) stock remained $12.36 – $18.95 and the day range was $18.42 – $18.85.